What is Roivant Sciences's cash divested from deconsolidation?

Roivant Sciences (ROIV) reported cash divested from deconsolidation of $4.42M in Q1 2026.

How has Roivant Sciences's cash divested from deconsolidation changed year-over-year?

Roivant Sciences's cash divested from deconsolidation increased by 5870.3% year-over-year, from $74K to $4.42M.

Revenue$2.5M-66.7%

Cash & equivalents$1.4B+1,411%

Total debt$107.4M+7.3%

Total equity$4.5B-3.4%

Total assets$5.7B+5.0%

Operating cash flow-$163.8M+5.1%

CapEx$1.3M+55.5%

Free cash flow-$165.1M+4.8%

Market cap$22.61B+175%

Enterprise value$21.29B+157%

P/S2,736.9×+2,454×

Operating margin-9,130.5%-13,995pp

Net margin-6,079.9%-6,193pp

Return on equity-17.1%-17.7pp

Debt / equity0×0.0×

Current ratio18.4×-15.1×

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:CashDivestedFromDeconsolidation.

The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

What is Roivant Sciences's cash divested from deconsolidation?: Roivant Sciences (ROIV) reported cash divested from deconsolidation of $4.42M in Q1 2026.
How has Roivant Sciences's cash divested from deconsolidation changed year-over-year?: Roivant Sciences's cash divested from deconsolidation increased by 5870.3% year-over-year, from $74K to $4.42M.